As October marks Liver Most cancers Consciousness Month, consultants spotlight encouraging progress in therapy and analysis.Dr. Anjana Pillai, professor of medication and...
The U.S. Meals and Drug Adminsitration (FDA) has accepted Blenrep (belantamab mafodotin-blmf) together with Velcade (bortezomib) and dexamethasone (a mixture often known...
